Deep learning–driven bacterial cytological profiling to determine antimicrobial mechanisms in Mycobacterium tuberculosis
Proceedings of the National Academy of Sciences · 11.02.2025 · 122 (6)
DOI: 10.1073/pnas.2419813122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 06.02.2025. Verfasst von Diana Quach und 8 weiteren Autor:innen. Beteiligte Einrichtung: Linnaeus Bioscience, Inc., San Diego, CA 92109. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Deep Learning, Antitubercular Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bill and Melinda Gates Foundation (GF).
Abstract (Originalsprache)
Tuberculosis (TB), caused by Mycobacterium tuberculosis , remains a significant global health threat, affecting an estimated 10.6 million people in 2022. The emergence of multidrug resistant and extensively drug resistant strains necessitates the development of novel and effective drugs. Accelerating the determination of mechanisms of action (MOAs) for these drugs is crucial for advancing TB treatment. This study introduces MycoBCP, a unique adaptation of bacterial cytological profiling (BCP) tailored to M. tuberculosis , utilizing the application of convolutional neural networks (CNNs) within BCP to overcome challenges posed by traditional image analysis techniques. Using MycoBCP, we analyzed the morphological effects of various antimicrobial compounds on M. tuberculosis , capturing broad patterns rather than relying on precise cell segmentation. This approach circumvented issues such as cell clumping and uneven staining, which are prevalent in M. tuberculosis . In a blind test, MycoBCP accurately identified the MOA for 96% of the compounds, with a single misclassification of rifabutin, which was incorrectly categorized as affecting translation rather than transcription. The similar morphologies resulting from transcription and translation inhibition indicate a need for further refinement to distinguish them more effectively. Application of MycoBCP to a series of antitubercular agents successfully identified known MOAs and revealed unique effects, demonstrating its utility in early drug discovery and development. Our findings underscore the potential of CNN-based BCP to enhance the accuracy and efficiency of MOA determination, particularly for challenging pathogens like M. tuberculosis . MycoBCP represents a significant advancement in TB drug development, offering a robust and adaptable method for high-throughput screening of antimicrobial compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Linnaeus Bioscience, Inc., San Diego, CA 92109.
- Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109.
- Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98109.
- Department of Molecular Biology, University of California, San Diego, CA 92093.
ORCID-Profile: Marc Sharp, Tanya Parish, Joseph Sugie
Förderung
- Bill and Melinda Gates Foundation (GF)
Zitieren
APA
Quach, D., Sharp, M., Ahmed, S., Ames, L., Bhagwat, A., Deshpande, A., Parish, T., Pogliano, J., & Sugie, J. (2025). Deep learning–driven bacterial cytological profiling to determine antimicrobial mechanisms in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences, 122(6). https://doi.org/10.1073/pnas.2419813122
Vancouver
Quach D, Sharp M, Ahmed S, Ames L, Bhagwat A, Deshpande A, et al. Deep learning–driven bacterial cytological profiling to determine antimicrobial mechanisms in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences. 2025;122(6). doi:10.1073/pnas.2419813122
BibTeX
@article{Quach2025,
author = {Quach, Diana and Sharp, Marc and Ahmed, Sara and Ames, Lauren and Bhagwat, Amala and Deshpande, Aditi and Parish, Tanya and Pogliano, Joe and Sugie, Joseph},
title = {Deep learning–driven bacterial cytological profiling to determine antimicrobial mechanisms in Mycobacterium tuberculosis},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {6},
doi = {10.1073/pnas.2419813122}
}
EUVIMED